entocort 3 mg kapsler med modificeret udløsning, hårde
paranova danmark a/s - budesonid - kapsler med modificeret udløsning, hårde - 3 mg
beconase 50 mikrogram/dosis næsespray, suspension
paranova danmark a/s - beclometasondipropionatmonohydrat - næsespray, suspension - 50 mikrogram/dosis
dysport 500 enheder pulver til injektionsvæske, opløsning
paranova danmark a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder
duovent 1,25 + 0,5 mg/behol. inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder
paranova danmark a/s - fenoterolhydrobromid, ipratropiumbromid - inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder - 1,25 + 0,5 mg/behol.
skinoren 200 mg/g creme
paranova danmark a/s - azelainsyre - creme - 200 mg/g
pentasa 1 g depottabletter
paranova danmark a/s - mesalazin - depottabletter - 1 g
serc 8 mg tabletter
paranova danmark a/s - betahistindihydrochlorid - tabletter - 8 mg
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
purimmun 50 mg tabletter
2care4 generics aps - mercaptopurin - tabletter - 50 mg
azacitidine "ever pharma" 25 mg/ml pulver til injektionsvæske, suspension
ever valinject gmbh - azacitidin - pulver til injektionsvæske, suspension - 25 mg/ml